J. Carroll

J.
Martin Carroll is Chairman at Esperion Therapeutics, Inc. since 2022.
Mr. Carroll is Lead Director at Catalent Pharma Solutions, Inc. since 2021.
Former roles include President & Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc. from 2003 to 2011; Chairman at Inotek Pharmaceuticals Corp.
from 2016 to 2018; Independent Director at VIVUS, Inc. from 2013 to 2014; Director at Accredo Health, Inc. from 2004 to 2005; Independent Director at Keenova Therapeutics Plc from 2013 to 2022; Director at Boehringer Ingelheim Corp.
from 2011 to 2012; Director at Pharmaceutical Research & Manufacturers of America; Director at Durata Therapeutics, Inc. in 2014; Independent Director at TherapeuticsMD, Inc. from 2015 to 2021; Independent Director at Catalent, Inc. from 2023 to 2024; Executive VP-Customer Marketing & Sales at Merck & Co., Inc. from 1976 to 2001; Global Head-Strategy & Development at Boehringer Ingelheim GmbH from 2012 to 2013; Trustee at Gwynedd-Mercy College.
Education includes an MBA from Babson College and undergraduate studies at Holy Cross College (Indiana).